Total Payments
$2,481
2024 Payments
$896.40
Companies
16
Transactions
158
Medicare Patients
465
Medicare Billing
$67,783
Payment Breakdown by Category
Food & Beverage$2,315 (93.3%)
Education$165.02 (6.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,315 | 154 | 93.3% |
| Education | $165.02 | 4 | 6.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $655.67 | 46 | $0 (2024) |
| ITI, Inc. | $499.34 | 27 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $359.23 | 22 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $287.44 | 18 | $0 (2024) |
| Lundbeck LLC | $128.76 | 9 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $117.22 | 8 | $0 (2024) |
| Alkermes, Inc. | $105.23 | 7 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $72.35 | 5 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $60.88 | 4 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $53.14 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $896.40 | 47 | ABBVIE INC. ($246.88) |
| 2023 | $740.10 | 50 | ITI, Inc. ($254.37) |
| 2022 | $525.31 | 42 | ABBVIE INC. ($168.50) |
| 2021 | $318.70 | 19 | ITI, Inc. ($122.28) |
All Payment Transactions
158 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Neuropsychiatry | ||||||
| 12/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Neuropsychiatry | ||||||
| 12/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.86 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Central Nervous System | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $113.46 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Neuropsychiatry | ||||||
| 10/15/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: Central Nervous System | ||||||
| 10/10/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: CNS | ||||||
| 09/26/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: PSYCHIATRY | ||||||
| 09/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: PSYCHIATRY | ||||||
| 08/15/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Central Nervous System | ||||||
| 08/02/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $4.89 | General |
| Category: Central Nervous System | ||||||
| 07/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.82 | General |
| Category: PSYCHIATRY | ||||||
| 07/16/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: PSYCHIATRY | ||||||
| 06/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: BH | ||||||
| 05/30/2024 | Janssen Pharmaceuticals, Inc | INVEGA (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Neuroscience | ||||||
| 05/30/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $5.33 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 164 | 528 | $87,795 | $31,422 |
| 2022 | 3 | 212 | 516 | $86,220 | $35,693 |
| 2021 | 2 | 24 | 28 | $580.00 | $188.29 |
| 2020 | 2 | 65 | 83 | $1,490 | $480.11 |
Total Patients
465
Total Services
1,155
Medicare Billing
$67,783
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 123 | 445 | $73,425 | $25,223 | 34.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 68 | $11,220 | $4,723 | 42.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 15 | $3,150 | $1,476 | 46.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 145 | 415 | $68,475 | $28,170 | 41.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 77 | $12,705 | $5,268 | 41.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 24 | 24 | $5,040 | $2,255 | 44.7% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 13 | 15 | $450.00 | $145.65 | 32.4% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 11 | 13 | $130.00 | $42.64 | 32.8% |
| 83037 | Hemoglobin a1c level | Office | 2020 | 28 | 33 | $990.00 | $317.58 | 32.1% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2020 | 37 | 50 | $500.00 | $162.53 | 32.5% |
About Jinal Patel, ARNP
Jinal Patel, ARNP is a Nurse Practitioner healthcare provider based in Glassboro, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2018. The National Provider Identifier (NPI) number assigned to this provider is 1710464110.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jinal Patel, ARNP has received a total of $2,481 in payments from pharmaceutical and medical device companies, with $896.40 received in 2024. These payments were reported across 158 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,315).
As a Medicare-enrolled provider, Patel has provided services to 465 Medicare beneficiaries, totaling 1,155 services with total Medicare billing of $67,783. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Psychiatric/Mental Health
- Location Glassboro, NJ
- Active Since 07/27/2018
- Last Updated 10/26/2022
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1710464110
Products in Payments
- VRAYLAR (Drug) $655.67
- CAPLYTA (Drug) $552.48
- REXULTI (Drug) $295.25
- Austedo XR (Drug) $127.95
- INGREZZA (Drug) $117.22
- ARISTADA (Drug) $105.23
- AUSTEDO (Drug) $90.71
- HETLIOZ (Drug) $72.35
- ABILIFY MAINTENA (Drug) $64.36
- ABILIFY ASIMTUFII (Drug) $56.59
- Auvelity (Drug) $47.36
- INVEGA SUSTENNA (Drug) $45.01
- PERSERIS (Drug) $29.29
- UZEDY (Drug) $29.08
- AZSTARYS (Drug) $19.67
- LATUDA (Drug) $18.50
- INVEGA (Drug) $15.87
- BEXSERO (Biological) $13.57
- TRINTELLIX (Drug) $12.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.